Key Highlights
- On November 18, 2026, VisionWave (NASDAQ:VWAV) gained roughly 57% and SeaStar Medical near 33%, clawing back a portion of the heavy declines seen on November 12.
- VisionWave retreated 18.74% after the bell, as its defence partnerships in Italy, India and Asia were reported to lack any customer orders.
- No catalyst for SeaStar Medical's rise could be identified. The company's third-quarter loss of USD 1.03 per share, released November 11, was larger than the USD 0.95 analysts had expected.
- Both stocks had shed over 40% on November 12, which means these bounces still leave them far below previous levels.
VisionWave: Gains Surrendered Within Hours
VisionWave (NASDAQ:VWAV) develops defence and security technology centred on radar and sensing products, and its shares surged on November 18. The stock had sunk around 43% on November 12 when investors doubted the value of a letter of intent, so the 57% bounce recovers some of that loss. Nothing confirmed explains the daytime advance, though the company did disclose that day a plan to assemble an international partner network spanning Italy, India and Asia. Post-close trading took 18.74% off the price because those partnerships contained no customer orders. This highlights a familiar pattern among small defence names: Partnership announcements generate buzz, but the market is pressing for firm contracts that carry defined revenue. The real measure will be whether these tie-ups convert into purchase orders, funded pilots or government awards. Meanwhile the shares are likely to stay erratic, moving sharply around each release. A modest Market Capitalisation also raises the prospect that an Equity raise to finance growth would press the stock, so filings deserve as much attention as partnership headlines.
SeaStar Medical: A Lift Without a Trigger
SeaStar Medical, which targets hyperinflammation in critically ill patients with its medical devices, climbed roughly 33% on November 18, yet no company statement accounting for the move turned up. Shares had lost about 48% on November 12, the session after third-quarter numbers showed a USD 1.03 per-share loss against a USD 0.95 consensus, while investors fixated on dwindling cash reserves. Ahead of that drop the stock was trading near USD 1.92, not far above the bottom of its 52-week span of USD 1.84 to USD 5.38, and the company was valued at only about USD 10 million. Given that size, small purchases can move the price a great deal. The firm has already raised equity and reduced executive compensation to stretch its cash, which signals dependence on outside capital. Any durable improvement would likely depend on proof of rising product uptake or a funding deal that avoids heavy dilution.
What Is Driving the Bounces
Bounces after deep sell-offs frequently owe more to short covering and speculation than to shifts in the underlying business. Both names were among the largest decliners on November 12, which could have attracted traders hunting for stretched stocks. Broader conditions gave little support, as the S&P 500 slipped 0.23%, a fifth consecutive loss, yet small caps did better with the Russell 2000 advancing 0.46%, and that relative firmness may have aided speculative positions. Prudence is in order. VisionWave's after-hours Reversal shows how fast a rally can unwind when news disappoints, whereas SeaStar Medical's jump rests on no confirmed event. Both carry tiny valuations and thin cash, so the risk of fresh share issuance is real. Watch upcoming disclosures, contract updates and financing moves, plus trading volumes, which will indicate whether buying interest widens or fades after the first surge.
Where Things Stand
VisionWave (NASDAQ:VWAV) and SeaStar Medical bounced 57% and 33% after steep November 12 declines, but VisionWave shed 18.74% after hours on partnerships lacking orders, and SeaStar showed no identifiable catalyst. Both stay highly volatile.






Please wait processing your request...